Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai
Patent
1990-03-30
1991-04-30
Evans, J. E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
C-o-group doai
514746, 568 14, 568843, 570136, C07C 1726, C07C 2118, A61K 3135
Patent
active
050118595
ABSTRACT:
This invention relates to certain novel di- and tetra-fluoro analogs of squalene and to their methods of use in lowering plasma cholesterol and in inhibiting squalene epoxidase in patients in need thereof.
REFERENCES:
patent: 3876672 (1975-04-01), Mrowca
patent: 4278819 (1981-07-01), Korff et al.
patent: 4455441 (1984-06-01), Prestwich
patent: 4839390 (1989-06-01), Naumann et al.
patent: 4876295 (1989-10-01), Peake
Sen, Stephanie E. et al., J. Med. Chem., 32:2152-2158 (1989).
Ceruti, Maurizio et al., Eur. J. Med. Chem., 22:199-208 (1987).
Hayashi, Sei-ichi et al., Chemistry Letters, Chemical Society of Japan, 983-986 (1979).
Edwards Michael L.
Jarvi Esa T.
McCarthy James R.
Evans J. E.
Merrell Dow Pharmaceuticals Inc.
Wille Louis J.
LandOfFree
Di- and tetra-fluoro analogs of squalene as inhibitors of squale does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Di- and tetra-fluoro analogs of squalene as inhibitors of squale, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Di- and tetra-fluoro analogs of squalene as inhibitors of squale will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-640672